## QUBT: Quantum Computing Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -5.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($8.42)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Quantum Computing Inc (QUBT) Stock: Latest News, Analyst Targets, and What Investors Should Watch Before Monday’s Open**
- Source: ts2.tech | 20251228T110916 | Somewhat-Bullish | Relevance: 100%
- This article provides an overview of Quantum Computing Inc (QUBT) stock as it approaches the end of 2025, highlighting its recent pullback, sector commentary, and varied analyst price targets. It delves into the company's financial standing, including significant liquidity and early-stage revenue, alongside key strategic developments like the proposed Luminar Semiconductor acquisition and a CEO transition. The piece also examines Wall Street forecasts, significant short interest, and crucial watchpoints for investors as the market reopens next week.

**2. Quantum Computing Stocks: IonQ, Rigetti, D-Wave and QUBT Slide Into Year-End—What to Watch Before Monday’s Open**
- Source: ts2.tech | 20251228T180956 | Neutral | Relevance: 91%
- Quantum computing stocks like IonQ (IONQ), Rigetti Computing (RGTI), D-Wave Quantum (QBTS), and Quantum Computing Inc. (QUBT) experienced significant declines on Friday, heading into the final trading week of the year with volatility exacerbated by thin liquidity. Despite this, the broader quantum narrative is being reinforced by progress from tech giants like Google and NVIDIA, maintaining investor interest in the sector's long-term potential. Investors are advised to watch for premarket liquidity, company-specific catalysts, and new commercial contracts as Monday's trading session approaches, emphasizing the ongoing tension between ambitious long-term narratives and near-term valuation challenges.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Ascendiant Capi | $25 | $40 | -38% |
| 2025-12-18 | Cantor Fitzgera | $15 | $15 | 0% |
| 2025-12-17 | Wedbush | $12 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Ascendiant Capi | main | Buy |
| 2025-12-18 | Cantor Fitzgera | reit | Neutral |
| 2025-12-17 | Wedbush | init | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 198.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 42.0% (+23.1%)
- Blackrock Inc.: 35.9% (+50.1%)
- Alyeska Investment G: 23.1% (+100.0%)
- Citadel Advisors Llc: 22.0% (+165.8%)
- Anson Funds Manageme: 18.5% (+14.9%)

### Key Risks

1. High beta (3.80) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_10 falling (-6.3% 5d) with bearish MACD, trend may be turning.
3. High short interest (22.7%, 1.8 days to cover): squeeze risk or crowded bearish bet.
4. Long-term trend broken: trading 24.9% below SMA200.
5. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.65 indicates undervaluation relative to growth. Balance sheet: strong liquidity (154.9x), low leverage (D/E 0.02). Revenue growth strong at 246% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.3B |
| Beta | 3.80 |
| 52W Range | $4.37 - $25.84 |
| Short Interest | 22.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.65 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 0.7% to -5.7% (-6.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.7pp (needs >3.0% for momentum thesis). Underperforming sector by 5.8pp, stock-specific weakness. Below SMA200 (0.75x), long-term trend not supportive. RSI neutral at 41. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.65% (CS: 3) | Weak |
| RSI_14 | 41.3 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 0.889x | Below |
| vs SMA50 | 0.825x | Below |
| vs SMA200 | 0.751x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $10.40
- **Stop Loss:** $8.42 (19.0% risk)
- **Target:** $12.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 555
- **Position Value:** $5,772.00
- **Portfolio %:** 5.77%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-03-19 (Est: $-0.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.05 | $0.07 | +239.4% |
| 2025Q2 | $-0.06 | $-0.06 | +1.2% |
| 2025Q1 | $-0.07 | $-0.05 | +29.8% |
| 2024Q4 | $-0.05 | $-0.10 | -97.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*